Nearly one covid vaccine in every seven to eight people worldwide was administered using HMD’s syringe
Hindustan Syringes & Medical Devices Ltd (HMD) has achieved another milestone of supplying 1.75 billion syringes of the total 13.3 billion COVID-19 vaccines administered globally, which means over 13 per cent of covid shots administered worldwide were using Kojak Selinge AD Syringes of HMD. Nearly one covid vaccine in every seven to eight people worldwide was administered using an HMD syringe.
HMD supplied over 921.7 million syringes from December 2020 till April 2023 to the government to help vaccinate over 1 billion people to date using more than 2 billion syringes to support the massive vaccination campaign to eradicate COVID-19 and help make India Aatmanirbhar.
Pardeep Sareen, Vice President for marketing of Hindustan Syringes and Medical Devices said, “Total Government orders HMD received till date from Dec 2020 are of more than 900 million pieces of 0.5 ml Kojak Selinge AD Syringes. In addition, HMD has been supplying various sizes of Dispo Van and Kojak Selinge AD Syringes in the private sector vaccination campaign. All orders received till date from December have been supplied on time or before time as per our commitments.”
HMD has made India proud with its global recognition as a key international supplier of critically needed syringes by supplying to COVAX facility of WHO (via UNICEF), approximately 650 million AD & Disposable syringes to UNICEF, over 150 million syringes to PAHO, both of which were later distributed to various developing nations around the world. On top of the same, over 45 million syringes were supplied as an emergency supply to Japan in 2020, mostly by air freight.
“We feel humbled and honoured to contribute to the International Vaccination Campaign along with extending our help to eradicate the covid pandemic globally. The prestigious vaccine bullets needed our humble guns. It was a huge responsibility, and we are glad we could shoulder the responsibilities with the government,” said Sohail Nath.
“India’s vaccination drive has been a role model for the world. To help vaccinate the world against covid, HMD’s manufacturing plants were operational 24/7. Our machines cranked out more than 4.2 lakh syringes of various types per hour at our factories spread over 11 acres in Faridabad industrial district in Haryana. HMD initially could produce over 250 crore assorted syringes of various types and sizes per year and we invested over Rs 100 crore from our resources, without government financial support to scale this to over 350 crores more syringes including expanding our vertical line of needle and capillary tubing capacities in our sincere quest for ensuring no syringe shortages,” said Rajiv Nath, MD, Hindustan Syringes and Medical Devices.
“But now we had to reduce our production of syringes drastically as covid vaccination rates dipped to negligible levels in the last quarter. Production of AD immunization syringes at our plant has fallen from 45-50 lakh units per day a year ago to 5-6 lakh now. We are repurposing our machines to produce Smart Kojak needle stick prevention syringes for curative healthcare drug delivery and are looking to penetrate overseas markets which have higher standards for injection safety than India currently for both patients as well as healthcare workers,” added Nath.
